# US 2021/0332161 A1 · Chlorinated derivative of hyaluronic acid, method of preparation thereof, a composition containing the derivative, and use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0332161 A1
- Document ID: US20210332161A1
- Status: Published application
- Kind: A1
- Application number: 17/270,693
- Filed: 2019-08-17
- Published: 2021-10-28
- Earliest claimed: 2018-08-23
- Assignees: Contipro A.S.
- Applicants: Contipro A.S.
- Inventors: Radovan BUFFA; Ivana BASARABOVA; Martina HERMANNOVA; Katerina KNOTKOVA; Jaromir KULHANEK; Josef CHMELAR; Tomás PITUCHA; Drahomira CHLADKOVA; Helena KREJCI; Hana VAGNEROVA; Martin SOJKA; Lubos SOBOTKA; Vladimir VELEBNY
- Web page: https://patentgrep.com/patent/US20210332161A1

## CPC

- C08B 37/0072: {Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates}
- A61K 31/728: Hyaluronic acid
- A61L 15/28: Polysaccharides or their derivatives {(A61L15/225 takes precedence)}
- A61L 15/46: Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
- A61L 27/20: Polysaccharides
- A61P 31/04: Antibacterial agents
- C08L 1/04: Oxycellulose; Hydrocellulose {, e.g. microcrystalline cellulose}
- C08L 1/284: {with hydroxylated hydrocarbon radicals}
- C08L 1/286: {substituted with acid radicals, e.g. carboxymethyl cellulose [CMC] (C08L1/282 takes precedence)}
- C08L 5/04: Alginic acid; Derivatives thereof
- C08L 5/08: Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
- A61L 2300/106: Halogens or compounds thereof, e.g. iodine, chlorite
- A61L 2300/404: Biocides, antimicrobial agents, antiseptic agents
- C08B: POLYSACCHARIDES; DERIVATIVES THEREOF (polysaccharides containing less than six saccharide radicals attached to each other by glycosidic linkages C07H; fermentation or enzyme-using processes C12P19/00; sugar industry C13; production of cellulose D21)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)

## Abstract

A chlorinated derivative of hyaluronic acid or of a modified hyaluronic acid (chloramide) is provided. The chloramide has an amidic group (—NH—CO—). The hydrogen of the amidic group is substituted by a chlorine atom, according to the structural formula —NCl—CO—. The substitution degree of the hyaluronic acid or of the modified hyaluronic acid by chlorine is in an amount of from 50 to 100 %.

## Claims

### Claim 1

A chlorinated derivative of hyaluronic acid or of a modified hyaluronic acid (chloramide), the chloramide having an amidic group (—NH—CO—), wherein the hydrogen of the amidic group is substituted by a chlorine atom, according to the structural formula —NCl—CO—, and wherein the substitution degree of the hyaluronic acid or of the modified hyaluronic acid by chlorine is in an amount of from 50 to 100%.

### Claim 2 (depends on 1)

The chlorinated derivative according to claim 1, wherein the modified hyaluronic acid is hyaluronic acid having an —OH group, a —CH2—OH, and a —CO—OH group and wherein:
(A) at least a portion of the —OH groups are substituted by a —O—CO—R2 group;
(B) at least a portion of the —CH2—OH groups are substituted by a —CH═O group;
(C) at least a portion of the —CO—OH groups are substituted by a —CO—OR2 group; wherein R2 is a linear or aromatic chain containing C1-C17 atoms; or
(D) any combination of (A), (B), and (C).

### Claim 3 (depends on 2)

The chlorinated derivative according to claim 2, wherein the modified hyaluronic acid is selected from the group comprising ethyl ester, benzyl ester, formyl, lauroyl (C12), palmitoyl (C16), caproyl (C6).

### Claim 4 (depends on 1)

The chlorinated derivative according to claim 1, wherein its molecular weight is 5 to 500 kg·mol−1.

### Claim 5 (depends on 1)

A method of preparation of the chloramide of hyaluronic acid or of a modified hyaluronic acid, according to claim 1, the method comprising:
preparing an aqueous solution of the initial hyaluronic acid or its modified derivative having the molecular weight within 40 to 2200 kg·mol−1, the concentration of the initial hyaluronic acid or its modified derivative being within 0.5 to 5% wt., based on a total weight of the aqueous solution;
adjusting the pH of the aqueous solution to the range of 2.5 to 7.5;
combining a chlorinating agent and the aqueous solution in the amount of 0.3 to 1.5 equivalents with respect to a hyaluronan disaccharide to form a mixture;
exposing the mixture for 5 to 72 hours to a temperature of from 5 to 40° C. to react; and
isolating the chloramide by precipitation.

### Claim 6 (depends on 5)

The method of preparation according to claim 5, wherein the pH is adjusted to the range of 4 to 6.

### Claim 7 (depends on 5)

The method of preparation according to claim 5, wherein the pH is adjusted by adding acetic acid in the amount of 0.2 to 7 equivalents with respect to the hyaluronan disaccharide.

### Claim 8 (depends on 5)

The method of preparation according to claim 5, wherein the chlorinating agent is trichloroisocyanuric acid or a sodium salt of dichloroisocyanuric acid.

### Claim 9 (depends on 1)

An antimicrobial, antifungal and antivirus composition, wherein the composition comprises:
the derivative according to claim 1 in a concentration of from 10 to 99% wt., based on a total weight of the composition; and
an additive selected from the group of water, sodium chloride, calcium chloride, glycerol, hyaluronic acid, chondroitin sulfate, sodium alginate, oxy-cellulose, carboxymethyl cellulose, hydroxyethyl cellulose, a modified hyaluronic acid, and combinations thereof, with the proviso that when the additive comprises a modified hyaluronic acid;
(A) at least a portion of the —OH groups of modified hyaluronic acid are substituted by a —O—CO—R2 group;
(B) at least a portion of the —CH2—OH groups are substituted by a —CH═O group;
(C) at least a portion of the —CO—OH groups are substituted by a —CO—OR2 group, wherein R2 is a linear or aromatic chain containing C1-C17 atoms; or
(D) any combination of (A), (B), and (C).

### Claim 10 (depends on 9)

The composition according to claim 9, wherein the composition is in the form of a solution or a gel in an aqueous solution, wherein the content of the chloramide in the composition, calculated in terms of the dry matter, is within the range of from 10 to 100%.

### Claim 11 (depends on 9)

The composition according to claim 9, wherein the composition is in the form of a solid substrate selected from the group of a self-supporting film, lyophilisate, a layer of staple fibres, an endless fibre, a woven fabric, knitted fabric, braided fabric, a layer of nanofibers, and combinations thereof, and wherein the content of the chloramide in the composition, calculated in terms of the dry matter, is within the range of from 10 to 100%.

### Claim 12 (depends on 1)

The chlorinated derivative according to claim 1, utilized for the preparation of wound covers or for the preparation of implantable medical devices.

### Claim 13 (depends on 9)

The composition according to claim 9, utilized for the preparation of wound covers or for the preparation of implantable medical devices.
